Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
about
Current and emerging azole antifungal agentsAntifungal activity of 3'-deoxyadenosine (cordycepin)Treatment of cryptococcosis in the setting of HIV coinfection.The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.The past, present and future of antimycotic combination therapy.Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivoEfficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephrInteraction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasisInteractions between triazoles and amphotericin B against Cryptococcus neoformans.Fluconazole in transplant recipients: options and limitations.Use of amphotericin B with azole antifungal drugs: what are we doing?Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.Toward more effective antifungal therapy: the prospects of combination therapy.Combination treatment of invasive fungal infections.Combination antifungal therapy: the new frontier.Combination antifungal therapy for the treatment of invasive yeast and mold infections.In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.Lysine enhances the effect of amphotericin B against Candida albicans in vitro.Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.Combined effect of liposomal and conventional amphotericin B in a mouse model of systemic infection with Candida albicans.
P2860
Q24550733-D5D3E0B1-8455-4BB6-A2F8-6E5CEB4BD13AQ28379548-C3AF6F58-C13F-4AB2-9DDF-C6C85ED47438Q30366117-044D56F9-E0FD-46EA-9982-19255EB07B8DQ31893406-3B081B63-9CB2-4393-825A-BBEFAC8BF5D0Q33693370-633E3D6C-DE0D-4D3B-ABBF-651D7544B4E1Q33760507-4E84FE6F-9B96-4B96-B27C-F737145F190FQ33803508-F5E65B3A-2842-4D52-B60A-402C396E3B5DQ33978188-3B1A426A-2F12-43AF-AF9B-3A7875493F69Q33978197-1456D05E-8D2A-451C-A6DE-1D8559F0B556Q33980421-C17C7EE9-5CF8-4ADF-A9BF-D64217B87D8CQ33980497-AEFF9FF0-0BA0-43FF-A956-163B6582F773Q34294909-C6B9861E-CC3E-403F-8201-D577B7D2C487Q35117932-CB678EC9-B494-434C-8977-E4D85DB22F6DQ35136738-6D1EB585-3D75-4E36-B588-99D949CB103AQ35139011-CBCEA8F8-A79A-4267-BDAA-09DB16AB5D6AQ35828187-B8A2C2A6-44AC-4669-B214-633C12463080Q36011378-1703E59A-97B8-4B4B-93D3-DAC645D81DA6Q36895652-7430859C-4BB8-4603-92BA-91584BE3D152Q37000091-61883803-4787-4339-9727-2E5CA8EA66A8Q37489291-5A163766-5E74-4A48-B418-9467E68A8A13Q39476255-55F12D58-0FD4-41FF-82AF-CCBA12AB367CQ39658166-2766A459-4343-42A8-A07E-B14FEB305313Q39955190-0F898A67-23C0-41EA-8469-E17E54306327Q40854042-00CE1982-D13C-40B8-B9EF-2E772D50982FQ42146510-A8079396-FF35-46C2-A9DC-2B9CA0066215Q44440960-6D4032BB-E40F-42CC-AFAD-93003C12F938Q45031123-E1B52846-53BA-48BF-8DF4-122030B4568C
P2860
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@ast
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@en
type
label
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@ast
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@en
prefLabel
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@ast
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@en
P2093
P2860
P356
P1476
Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.3.598
P407
P577
1995-03-01T00:00:00Z